Daré Bioscience, Inc. (DARE): Margin dodolan operasi

Daré Bioscience (DARE) - logo korporat

Dare Bioscience, Inc. (DARE) generates revenue through the sale of women's health products and royalties. The GURU.Markets portal features a chart where the operating margin reflects a turning point due to the lack of proprietary manufacturing facilities and total reliance on third-party contractors. The modest impact of the first gel's sales defines the current trend, and the latest parameter is -746.10.

DARE: Rentabilitas operasi darebioscience.com 04.07.2022 - 19.11.2026

Rincian metrik lan analitis perusahaan darebioscience.com (DARE)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Daré Bioscience, Inc., DARE
Barang utama Dare Bioscience, Inc.

For the biopharmaceutical business of Dare Bioscience, Inc. (DARE), the average monthly operating margin serves as an indicator of R&D cost management efficiency in the absence of capital expenditures in manufacturing. This metric is calculated as the ratio of operating profit to revenue, demonstrating the share of net income from product sales before accounting for debt load and taxes, which allows for an assessment of scaling potential through partner royalties.